Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1321)	1/7/2003 4:15:27 PM
From: tuck	Read Replies (1) \| Respond to of 1784

>>I said that productivity remained a focus, in face of the "no big ticket" environment. Part of that effort involves determining how to spend less on reagents and consumables.<< Indeed, though it was not clear to me that this was being accomplished outside of the industrial sequencing arena -- ABI being the poster child here, as it has blamed its slowdown in its reagents business to customers getting more efficient with the use of said reagents. Supposedly microfluidics and arrays are going to accomplish this someday. Also have read that disposal costs are a significant percentage of costs associated with reagents. >>Fisher sells the stuff that you need to do such.<< It's a big catalog, can you be more specific? TIA and Cheers, Tuck